ExodusPoint Capital Management, LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2022$313,000
+58.9%
155,020
+112.7%
0.00%
+100.0%
Q4 2021$197,000
-45.0%
72,868
-9.1%
0.00%
-60.0%
Q3 2021$358,000
-47.7%
80,202
-32.1%
0.01%
-37.5%
Q2 2021$685,000
+254.9%
118,079
+256.0%
0.01%
+100.0%
Q3 2020$193,000
-25.8%
33,169
-14.0%
0.00%
-42.9%
Q2 2020$260,000
+101.6%
38,562
+210.6%
0.01%
+250.0%
Q4 2019$129,00012,4150.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders